Common use of Exclusive Access Clause in Contracts

Exclusive Access. From the time at which a Research Project is ---------------- begun and continuing through a one-year period which shall commence at the beginning of the calendar quarter following the calendar quarter in which delivery of a proper notice of a complete Project Data Set is made pursuant to Section 2.1.2(c) and access to such complete Project Data Set is given to GENENTECH (the "Exclusive Evaluation Period"), GENENTECH shall have the right Confidential Treatment Requested 1. CURAGEN shall keep GENENTECH reasonably informed of the results of any such research and patent applications and patents relating to such research on a confidential and timely basis in order to allow GENENTECH to make informed decisions regarding the exercise of its option and license rights hereunder. All inventions conceived or made during such research which relate to the Clone, the proteins derived therefrom (including antibodies), homologs or mutants with substantially the same biological activity as such Clone, or uses thereof, shall be deemed Research Project Inventions subject to GENENTECH's option rights for such Clone under Article 7. All other inventions from such research shall be Extended Research Inventions and GENENTECH will have rights to such Extended Research Inventions and Extended Research Patent Rights resulting therefrom as provided in Article 7 hereof and in Section 2.3 of the License Agreement attached hereto as Appendix C.

Exclusive Access. From the time at which a Research Project is ---------------- begun and continuing through a one-year period [XXXXX] which shall commence at the beginning of the calendar quarter following the calendar quarter in which delivery of a proper notice of a complete Project Data Set is made pursuant to Section 2.1.2(c) and access to such complete Project Data Set is given to GENENTECH (the "Exclusive Evaluation Period"), GENENTECH shall have the right Confidential Treatment Requested 1. CURAGEN shall keep GENENTECH reasonably informed of the results of any such research and patent applications and patents relating to such research on a confidential and timely basis in order to allow GENENTECH to make informed decisions regarding the exercise of its option and license rights hereunder. All inventions conceived or made during such research which relate to the Clone, the proteins derived therefrom (including antibodies), homologs or mutants with substantially the same biological activity as such Clone, or uses thereof, shall be deemed Research Project Inventions subject to GENENTECH's option rights for such Clone under Article 7. All other inventions from such research shall be Extended Research Inventions and GENENTECH will have rights to such Extended Research Inventions and Extended Research Patent Rights resulting therefrom as provided in Article 7 hereof and in Section 2.3 of the License Agreement attached hereto as Appendix C.